Symbol Insights

You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.

Insights for Bristol-Myers Squibb Company
New York Stock Exchange: BMY
11 - Losing Steam - loss-making but can fund turnaround
Sector: Health & Fitness
Industry: Medicine - Production & Distribution
Today's Price
updated on: 		56.85 (-0.99%)
Open 57.46 (-1.06%)
High (Upside %) 57.71 (1.51%)
Low (Downside %) 56.19 (1.17%)
P. Close 57.42 (-0.99%)
Open-High % 0.44%
Open-Low % 2.21%
Low-High % 2.71%
Active Buy Quantity 0
Active Sell Quantity 0
% Overtraded
Current Mood bearish
Previous Data
data from:
Open-High % 0.44%
Open-Low % 2.21%
Low-High % 2.71%
Open-Close % -1.06%
Low-Close % 1.17%
High-Close % 1.49%

BMY is a Stock listed in the US on the New York Stock Exchange under the ticker 'BMY'

Company Profile

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

source:https://finance.yahoo.com/BMY/profile

Predicted Prices
Key Low (open) Low (high) Close-Down (open) Close-Down (high) Close-Up (open) Close-Up (low) High (open) High (low)
Low Volatility 57.33
41.64% hit 		56.97
54.11% hit 		57.13
17.71% hit 		57.48
43.77% hit 		57.69
14.26% hit 		56.44
42.64% hit 		57.66
41.25% hit 		56.92
54.11% hit
Average Volatility 56.86
30.9% hit 		56.33
35.68% hit 		56.86
14.19% hit 		56.93
32.23% hit 		58.14
14.72% hit 		56.85
31.17% hit 		58.37
31.5% hit 		57.57
35.68% hit
High Volatility 55.81
3.91% hit 		55.26
3.78% hit 		56.21
3.51% hit 		55.72
3.51% hit 		59.13
3.65% hit 		58.01
3.78% hit 		59.6
4.11% hit 		58.69
3.78% hit

BMY's predicted prices using open from of 57.46 and data until date . Current Price is 56.85

Basic Stats
Market Cap-Display Market Cap-Actual Market Cap Enterprise Value-Display Enterprise Value-Actual Enterprise Value Trailing P/E Forward P/E PEG Ratio (5yr expected) Price/Sales Price/Book Enterprise Value/Revenue Enterprise Value/EBITDA Profit Margin Operating Margin Return on Assets Return on Equity Revenue-Display Revenue-Actual Revenue Quarterly Revenue Growth EBITDA-Display EBITDA-Actual EBITDA Diluted EPS Quarterly Earnings Growth Total Cash-Display Total Cash-Actual Total Cash Total Debt-Display Total Debt-Actual Total Debt Total Debt/Equity Current Ratio Operating Cash Flow-Display Operating Cash Flow-Actual Operating Cash Flow Levered Free Cash Flow-Display Levered Free Cash Flow-Actual Levered Free Cash Flow % Held by Insiders % Held by Institutions
119.18 B 119180000000.0 119.18 162.48 B 162480000000.0 162.48 22.79 8.37 2.04 2.51 6.95 3.43 32.04 -15.30% 18.48% 6.07% -31.33% 47.44 B 47440000000.0 47.44 8.40% 19.16 B 19160000000.0 19.16 -3.58 -37.20% 8.09 B 8090000000.0 8.09 51.44 B 51440000000.0 51.44 2.9905 1.24 15.0 B 15000000000.0 15.0 17.52 B 17520000000.0 17.52 0.12% 78.49%

source:https://finance.yahoo.com/BMY/key-statistics

Reading Information

source:https://finance.yahoo.com/BMY/key-statistics

source:https://www.google.com/finance/quote/BMY:NYSE

source:https://finance.yahoo.com/BMY/analysis

source:https://finance.yahoo.com/BMY/fair-value

Upside-Downside Spread
Key Weighted 5D 1M 3M 6M 1Y 3Y 10Y
Upside % (high) 8.33% 6.17% (60.36) 7.48% (61.1) 7.48% (61.1) 7.48% (61.1) 7.48% (61.1) 43.25% (81.44) 43.25% (81.44)
Downside % (low) 5.66% 1.16% (56.19) 3.59% (54.81) 5.07% (53.97) 18.7% (46.22) 30.78% (39.35) 30.78% (39.35) 30.78% (39.35)
Spread % 2.67% 5.01% 3.89% 2.41% -11.22% -23.31% 12.47% 12.47%

BMY's price used for computing the stats is 56.85 as on date

Cumulative Return Percent
Key Today 5D 1M 3M 6M 1Y 3Y 10Y
Last Price-Trend PrevClose 0.0% -3.56% 0.3% 1.94% 15.9% 15.41% -12.27% -5.61%
Last Price 56.85 56.85 56.85 56.85 56.85 56.85 56.85 56.85
Trend-Previous Close 56.85 58.95 56.68 55.77 49.05 49.26 64.8 60.23

BMY's symbol cumulative return percent is computed basis data from date

Return Velocity
5D 2W 1M 3M 6M 1Y
5D window
Metric Mean Median Stdev
Overall -1.16% -1.07% 2.07%
Up 1.32% 1.52% 0.78%
Down -1.94% -2.91% 1.71%
5D Opportunity: BUY-APPROACHING
returns: -3.56% (3.64%), p.close: 58.95
entry: 56.8, exit: 57.1, return: 0.52%
Metric Mean Median Stdev
Overall 0.71% 0.31% 3.33%
Up 3.07% 1.86% 2.6%
Down -1.18% -0.41% 1.46%
5D Opportunity: BUY-ACTIVE
returns: -3.56% (2.64%), p.close: 58.95
entry: 57.39, exit: 57.17, return: -0.39%
Metric Mean Median Stdev
Overall 0.86% 0.53% 3.02%
Up 2.46% 1.63% 2.31%
Down -1.12% -0.41% 1.3%
5D Opportunity: BUY-ACTIVE
returns: -3.56% (2.42%), p.close: 58.95
entry: 57.52, exit: 57.48, return: -0.07%
Metric Mean Median Stdev
Overall 0.8% 0.23% 3.26%
Up 2.58% 1.75% 2.69%
Down -1.59% -1.01% 1.66%
5D Opportunity: BUY-ACTIVE
returns: -3.56% (3.25%), p.close: 58.95
entry: 57.03, exit: 57.16, return: 0.23%
Metric Mean Median Stdev
Overall 0.84% 0.38% 3.2%
Up 2.51% 1.74% 2.7%
Down -1.54% -1.17% 1.53%
5D Opportunity: BUY-ACTIVE
returns: -3.56% (3.07%), p.close: 58.95
entry: 57.14, exit: 57.29, return: 0.26%
Metric Mean Median Stdev
Overall 0.44% 0.37% 3.91%
Up 2.42% 1.63% 2.93%
Down -1.83% -1.39% 2.01%
5D Opportunity: BUY-APPROACHING
returns: -3.56% (3.84%), p.close: 58.95
entry: 56.69, exit: 56.86, return: 0.31%
2W window
Metric Mean Median Stdev
Overall 3.81% 5.18% 4.25%
Up 6.67% 7.57% 2.67%
Down -0.86% 0% 1.64%
2W Opportunity: BUY-ACTIVE
returns: -4.73% (2.5%), p.close: 59.67
entry: 58.18, exit: 60.23, return: 3.52%
Metric Mean Median Stdev
Overall 1.53% 0.78% 4.03%
Up 3.77% 2.2% 3.4%
Down -1.88% -2.18% 1.57%
2W Opportunity: BUY-ACTIVE
returns: -4.73% (3.46%), p.close: 59.67
entry: 57.61, exit: 57.73, return: 0.21%
Metric Mean Median Stdev
Overall 1.73% 1.35% 4.35%
Up 4.19% 2.98% 3.74%
Down -2.14% -2.09% 1.95%
2W Opportunity: BUY-ACTIVE
returns: -4.73% (4.09%), p.close: 59.67
entry: 57.23, exit: 57.88, return: 1.14%
Metric Mean Median Stdev
Overall 2.13% 1.79% 4.21%
Up 4.48% 3.15% 4.33%
Down -1.89% -1.61% 1.83%
2W Opportunity: BUY-ACTIVE
returns: -4.73% (3.72%), p.close: 59.67
entry: 57.45, exit: 58.23, return: 1.36%
Metric Mean Median Stdev
Overall 0.86% 0.79% 5.35%
Up 3.92% 2.98% 4.32%
Down -2.66% -1.95% 2.75%
2W Opportunity: BUY-APPROACHING
returns: -4.73% (5.41%), p.close: 59.67
entry: 56.44, exit: 56.95, return: 0.9%
1M window
Metric Mean Median Stdev
Overall 1.01% 1.73% 3.7%
Up 4.0% 4.26% 2.59%
Down -3.2% -3.02% 1.57%
1M Opportunity:
returns: 0.3% (6.58%), p.close: 56.68
entry: 60.41, exit: 59.76, return: 1.08%
Metric Mean Median Stdev
Overall 3.07% 2.27% 5.73%
Up 6.34% 5.39% 4.7%
Down -2.91% -2.56% 1.84%
1M Opportunity:
returns: 0.3% (11.04%), p.close: 56.68
entry: 62.94, exit: 61.21, return: 2.74%
Metric Mean Median Stdev
Overall 5.39% 5.08% 6.27%
Up 8.61% 7.05% 6.65%
Down -2.24% -1.94% 1.9%
1M Opportunity:
returns: 0.3% (15.26%), p.close: 56.68
entry: 65.33, exit: 63.12, return: 3.39%
Metric Mean Median Stdev
Overall 1.61% 2.27% 8.06%
Up 6.36% 4.95% 6.06%
Down -4.22% -3.22% 4.14%
1M Opportunity:
returns: 0.3% (12.42%), p.close: 56.68
entry: 63.72, exit: 62.53, return: 1.86%

BMY's symbol current price is 56.85 (0.0%) as on . Yesterday's close was 56.85. It's return velocities are computed basis data from date .

Win Percent
Key Weighted 5D 1M 3M 6M 1Y 3Y
Open-High (> 1.0%) 65.11% 80.0% 63.64% 46.97% 48.48% 47.22% 39.02%
Open-Low (> 1.0%) 33.22% 20.0% 36.36% 48.48% 48.48% 46.43% 39.81%
Open-Close-Up (> 0.5%) 29.8% 20.0% 36.36% 36.36% 38.64% 35.32% 31.35%
Open-Close-Down (> 0.5%) 24.62% 20.0% 18.18% 37.88% 36.36% 36.11% 34.52%
Low-Close-Up (> 1.0%) 42.54% 40.0% 45.45% 42.42% 46.21% 44.05% 39.15%
High-Close-Down (> 1.0%) 60.14% 80.0% 45.45% 50.0% 46.97% 45.63% 39.29%

BMY's symbol win percent is computed basis data from date

Associated Tags